• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nebulization of NanoCrystals: production of a respirable solid-in-liquid-in-air colloidal dispersion.

作者信息

Wiedmann T S, DeCastro L, Wood R W

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis 55455, USA.

出版信息

Pharm Res. 1997 Jan;14(1):112-6. doi: 10.1023/a:1012024021511.

DOI:10.1023/a:1012024021511
PMID:9034231
Abstract
摘要

相似文献

1
Nebulization of NanoCrystals: production of a respirable solid-in-liquid-in-air colloidal dispersion.纳米晶体的雾化：制备可吸入的气-液-固胶体分散体。
Pharm Res. 1997 Jan;14(1):112-6. doi: 10.1023/a:1012024021511.
2
An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization.通过超声雾化对纳米晶丙酸倍氯米松胶体分散体进行的体外评估。
Eur J Pharm Biopharm. 1999 Nov;48(3):207-15. doi: 10.1016/s0939-6411(99)00049-1.
3
PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.聚酰胺-胺型树枝状大分子作为通过雾化进行肺部给药的气溶胶药物纳米载体。
Int J Pharm. 2014 Jan 30;461(1-2):242-50. doi: 10.1016/j.ijpharm.2013.11.023. Epub 2013 Nov 22.
4
Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages.来自氢氟烷烃-134a定量吸入器的超细微皮质类固醇气雾剂：潜在的优缺点
Chest. 1999 Feb;115(2):316-8. doi: 10.1378/chest.115.2.316.
5
Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients.通过不同雾化器雾化的丙酸倍氯米松对哮喘患者的疗效。
Eur Rev Med Pharmacol Sci. 2001 Mar-Apr;5(2):43-51.
6
Applicability of an ultrasonic nebulization system for the airways delivery of beclomethasone dipropionate in a murine model of asthma.超声雾化系统在小鼠哮喘模型中用于气道递送丙酸倍氯米松的适用性。
Pharm Res. 2006 Aug;23(8):1765-75. doi: 10.1007/s11095-006-9029-y.
7
Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.在基于134a的加压定量吸入器中平衡乙醇助溶剂浓度与产品性能。
J Aerosol Med. 2003 Summer;16(2):167-74. doi: 10.1089/089426803321919924.
8
[Efficacy and safety of beclomethasone dipropionate HFA.].丙酸倍氯米松HFA的疗效与安全性。
Recenti Prog Med. 2017 Nov;108(11):1-11. doi: 10.1701/2813.28446.
9
Matching the device to the patient.使设备与患者相匹配。
Pediatr Pulmonol Suppl. 2004;26:26-9. doi: 10.1002/ppul.70038.
10
Targeting drug delivery and the small airways in asthma.
Hosp Med. 1998 Jun;59(6):488-91.

引用本文的文献

1
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.用于治疗炎症性肺部疾病的基于纳米技术的可吸入药物递送系统。
Pharmaceutics. 2025 Jul 9;17(7):893. doi: 10.3390/pharmaceutics17070893.
2
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery.吸入式纳米颗粒系统：组成、制造和气溶胶传递。
J Aerosol Med Pulm Drug Deliv. 2024 Aug;37(4):202-218. doi: 10.1089/jamp.2024.29117.mk.
3
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.肺部给药的纳米制剂：过去、现在与未来展望
Pharmaceutics. 2024 Jan 24;16(2):161. doi: 10.3390/pharmaceutics16020161.
4
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.肺部疾病中的气道黏液：克服气道黏液屏障的黏附性和穿透性颗粒。
Int J Pharm. 2023 Mar 5;634:122661. doi: 10.1016/j.ijpharm.2023.122661. Epub 2023 Feb 1.
5
Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.将含美洛昔康的纳米混悬液转化为无表面活性剂的固体组合物以提高产品稳定性和药物生物利用度实现快速镇痛
Drug Des Devel Ther. 2019 Nov 28;13:4007-4020. doi: 10.2147/DDDT.S220876. eCollection 2019.
6
Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.含环丙沙星纳米晶体脂质体的气溶胶性能与稳定性
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):411-22. doi: 10.1089/jamp.2015.1241. Epub 2015 Oct 15.
7
Particle engineering for pulmonary drug delivery.用于肺部给药的颗粒工程。
Pharm Res. 2007 Mar;24(3):411-37. doi: 10.1007/s11095-006-9174-3.
8
Particle size analysis in pharmaceutics: principles, methods and applications.制药学中的粒度分析：原理、方法与应用
Pharm Res. 2007 Feb;24(2):203-27. doi: 10.1007/s11095-006-9146-7. Epub 2006 Dec 27.
9
Production and characterization of a budesonide nanosuspension for pulmonary administration.
Pharm Res. 2002 Feb;19(2):189-94. doi: 10.1023/a:1014276917363.
10
Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.庆大霉素负载聚（L-丙交酯）微粒形成过程中工艺变量对残留溶剂去除及聚合物形态的影响
Pharm Res. 1998 Aug;15(8):1233-7. doi: 10.1023/a:1011991808423.